Literature DB >> 8648092

Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases.

L Olcese1, P Lang, F Vély, A Cambiaggi, D Marguet, M Bléry, K L Hippen, R Biassoni, A Moretta, L Moretta, J C Cambier, E Vivier.   

Abstract

NK cells express cell surface receptors for MHC class I proteins (KIR). Engagement of these receptors inhibits NK cell cytotoxic programs. KIR can be expressed on T cells, and their engagement also results in inhibition of effector functions initiated by the CD3/TCR complex. While human KIR genes belong to the Ig gene superfamily, mouse KIR belong to a family of dimeric lectins. Despite these distinct evolutionary origins, we show here that both HLA-Cw3-specific human p58.183 receptors and H-2D d/k-specific mouse Ly49A receptors recruit the same protein tyrosine phosphatases, PTP1C and PTP1D, upon phosphorylation of critical intracytoplasmic tyrosine residues. These results document a common pathway by which diverse KIR can down-regulate NK and T cell activation programs, and further define the sequence of the immunoreceptor tyrosine-based inhibitory motif (ITIM), initially described in FcgammaRIIB1, and expressed in both human and mouse KIR.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648092

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  73 in total

1.  Ly49A inhibitory receptors redistribute on natural killer cells during target cell interaction.

Authors:  M Eriksson; J C Ryan; M C Nakamura; C L Sentman
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

2.  H-2Dd engagement of Ly49A leads directly to Ly49A phosphorylation and recruitment of SHP1.

Authors:  M R Daws; M Eriksson; L Oberg; A Ullén; C L Sentman
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

3.  Alloreactivity and association of human natural killer cells with the major histocompatibility complex.

Authors:  E Mavoungou; A Sall; V Poaty-Mavoungou; F S Toure; P Yaba; A Delicat; J Lansoud-Soukate
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

4.  Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor.

Authors:  A Cambiaggi; C Verthuy; P Naquet; F Romagné; P Ferrier; R Biassoni; A Moretta; L Moretta; E Vivier
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

5.  Ly49Q, a member of the Ly49 family that is selectively expressed on myeloid lineage cells and involved in regulation of cytoskeletal architecture.

Authors:  Noriko Toyama-Sorimachi; Yusuke Tsujimura; Mikako Maruya; Atsuko Onoda; Toshiyuki Kubota; Shigeo Koyasu; Kayo Inaba; Hajime Karasuyama
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-19       Impact factor: 11.205

Review 6.  Natural killer cell tolerance: control by self or self-control?

Authors:  Baptiste N Jaeger; Eric Vivier
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-03-01       Impact factor: 10.005

7.  CD161B:ClrB interactions mediate activation of enhanced lysis of tumor target cells following NK cell:DC co-culture.

Authors:  Tianbing Yang; Melanie S Flint; Katie M Webb; William H Chambers
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

8.  Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation.

Authors:  Geraldine Ferjoux; Frederic Lopez; Jean-Pierre Esteve; Audrey Ferrand; Eric Vivier; Frederic Vely; Nathalie Saint-Laurent; Lucien Pradayrol; Louis Buscail; Christiane Susini
Journal:  Mol Biol Cell       Date:  2003-07-11       Impact factor: 4.138

9.  DAP12 impacts trafficking and surface stability of killer immunoglobulin-like receptors on natural killer cells.

Authors:  Tiernan J Mulrooney; Phillip E Posch; Carolyn Katovich Hurley
Journal:  J Leukoc Biol       Date:  2013-05-28       Impact factor: 4.962

Review 10.  Regulation of cell signaling by the protein tyrosine phosphatases, CD45 and SHP-1.

Authors:  T Ulyanova; J Blasioli; M L Thomas
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.